Related references
Note: Only part of the references are listed.Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Karen-Lise Garm Spindler et al.
CLINICAL CANCER RESEARCH (2012)
miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation
James F. Reid et al.
MOLECULAR CANCER RESEARCH (2012)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
Enrique Quintero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Impact of a Population-Based Colorectal Cancer Screening Program on Local Health Services Demand in Italy: A 7-Year Survey in a Northern Province
Fabrizio Parente et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
Marco Agostini et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
R. Mead et al.
BRITISH JOURNAL OF CANCER (2011)
Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
Dolores C. Garcia-Olmo et al.
CANCER RESEARCH (2010)
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
Maniesh van der Vaart et al.
CLINICAL BIOCHEMISTRY (2010)
Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
Elisa Danese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Circulating free tumor DNA and colorectal cancer
T. Lecomte et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Alain R. Thierry et al.
NUCLEIC ACIDS RESEARCH (2010)
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
M. Frattini et al.
CANCER LETTERS (2008)
Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: A potential diagnostic tool for therapy monitoring
Matthias Zitt et al.
DISEASE MARKERS (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Free circulating DNA as possible tumour marker in colorectal cancer
L. Boni et al.
SURGICAL ONCOLOGY-OXFORD (2007)
Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer
Emanuela Flamini et al.
CLINICAL CANCER RESEARCH (2006)
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence:: A prospective study
Emmanuelle Gormally et al.
CANCER RESEARCH (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers
JY Wang et al.
WORLD JOURNAL OF SURGERY (2004)
Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients
JL Ramirez et al.
CANCER LETTERS (2003)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release
M Stroun et al.
CLINICA CHIMICA ACTA (2001)
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
TH Lee et al.
TRANSFUSION (2001)
Somatic mutation screening: Identification of individuals harboring K-ras mutations with the use of plasma DNA
MS Kopreski et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
